Histological and Molecular Mechanisms of Pain in Patient With Chronic Pain From Adhesions
PAIN PAD
PAIN PAD Histological and Molecular Mechanisms of Pain in Patient With Chronic Pain From Adhesions
1 other identifier
observational
61
1 country
3
Brief Summary
11-20% of patients undergoing abdominal surgery develop chronic abdominal pain. Adhesions are a common cause of chronic pain following surgery. Adhesions develop after up to 90% of laparotomies and 70% of laparoscopic surgeries. Obviously, not all adhesions cause pain. It is still poorly understood why adhesions cause pain in some patients, while other patients with adhesions experience no pain. In this study we explore possible mechanism through which adhesions might cause pain. For this purpose we will assess expression of molecular mediators (such as TRPV-1, SP, and the neurokinin receptor), histological characteristics, and fecal microbioma that might be associated with pain.Expression of these factor will be compared to sample from 30 patients with chronic pain attributed to adhesions, and 30 patients undergoing a reoperation with adhsiolysis for reasons unrelated to pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2019
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2019
CompletedFirst Submitted
Initial submission to the registry
May 1, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedDecember 31, 2024
December 1, 2024
4.7 years
May 1, 2019
December 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
TRPV-1
mRNA expression levels of TRPV1 by quantitative polymerase chain reaction (qPCR)
during surgery
Secondary Outcomes (5)
TRPV-1 protein
during surgery
SP
during surgery
NK-1
during surgery
Nerve fibers
during surgery
Microbioma
12 months
Study Arms (2)
Pain patients
30 patients eligible for adhesiolysis because of chronic adhesion-related pain. Patients are recruited at the RadboudUMC, MUMC+ and Pantein hospital departments of surgery. These are patients with chronic pain after previous abdominal surgery who have been selected for operative treatment after evaluated with CineMRI. CineMRI is used to map adhesions. This technique has been established to provide insight in localization of adhesions in relation to the pain, and risk of bowel injury based on extensiveness of adhesions.
Control group
The control group will comprise of 30 patients undergoing an abdominal reoperation during which adhesiolysis has to be performed for reasons other than chronic adhesion-related pain.
Interventions
Preoperatively and at 12 months after surgery, patients will obtain a fecal stool sample for microbioma analysis. Adhesions that are cut and released to acquire access to the operative field are stored for molecular and histological analyses.
Eligibility Criteria
Chronic abdominal pain after surgery is a frequent condition.(13) At present the RadboudUMC, MUMC+, and Pantein hospital departments of surgery annually evaluate 60-80 patients each for chronic pain by cineMRI. Between 30-40 of these patients are expected to undergo surgical treatment. Yearly between 600-700 patients will undergo an elective abdominal reoperation at the participating departments of surgery. Thus there is ample surgical volume for this study.
You may qualify if:
- Patients between 18 and 75 years old scheduled for elective abdominal reoperation
- No present chronic abdominal pain
- No other diseases or syndromes that cause chronic pain (e.g. rheumatic arthritis)
You may not qualify if:
- A potential subject with chronic pain will be excluded from participation in this study in the following cases:
- Contra-indications for general anaesthesia and re-operation
- Inability to acquire informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Radboud University Medical Centerlead
- Maastricht University Medical Centercollaborator
- Maas Hospital Panteincollaborator
Study Sites (3)
Maasziekenhuis Pantein
Boxmeer, Gelderland, 5830 AB, Netherlands
Radboud University Medical Center
Nijmegen, Gelderland, 6500HB, Netherlands
Maastricht Universitair Medisch Centrum+
Maastricht, Limburg, 6202 AZ, Netherlands
Related Publications (5)
van den Beukel BAW, Stommel MWJ, van Leuven S, Strik C, IJsseldijk MA, Joosten F, van Goor H, Ten Broek RPG. A Shared Decision Approach to Chronic Abdominal Pain Based on Cine-MRI: A Prospective Cohort Study. Am J Gastroenterol. 2018 Aug;113(8):1229-1237. doi: 10.1038/s41395-018-0158-9. Epub 2018 Jun 27.
PMID: 29946174BACKGROUNDReed KL, Fruin AB, Bishop-Bartolomei KK, Gower AC, Nicolaou M, Stucchi AF, Leeman SE, Becker JM. Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. J Surg Res. 2002 Nov;108(1):165-72. doi: 10.1006/jsre.2002.6533.
PMID: 12443729BACKGROUNDten Broek RP, Issa Y, van Santbrink EJ, Bouvy ND, Kruitwagen RF, Jeekel J, Bakkum EA, Rovers MM, van Goor H. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ. 2013 Oct 3;347:f5588. doi: 10.1136/bmj.f5588.
PMID: 24092941BACKGROUNDKeszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, Ludidi S, Vanhoutvin S, Venema K, Dekker J, Szolcsanyi J, Masclee AA. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain. 2013 Oct;17(9):1299-306. doi: 10.1002/j.1532-2149.2013.00309.x. Epub 2013 Mar 25.
PMID: 23529955BACKGROUNDScotland RS, Chauhan S, Davis C, De Felipe C, Hunt S, Kabir J, Kotsonis P, Oh U, Ahluwalia A. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res. 2004 Nov 12;95(10):1027-34. doi: 10.1161/01.RES.0000148633.93110.24. Epub 2004 Oct 21.
PMID: 15499026BACKGROUND
Biospecimen
Samples from adhesions are taken. Fecal samples are taken for microbioma analysis.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard P ten Broek, MD, PhD
Radboud University Medical Center
- STUDY DIRECTOR
Harry van Goor, MD, PhD
Radboud University Medical Center
- STUDY CHAIR
Richard P ten Broek, MD, PhD
Radboud University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2019
First Posted
May 6, 2019
Study Start
April 9, 2019
Primary Completion
December 31, 2023
Study Completion
December 20, 2024
Last Updated
December 31, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- 12 months after publication of primary results
IPD will be shared upon reasonable request through DANS easy archive